Faecal calprotectin: a bright future for assessing disease activity in Crohn's disease

被引:12
|
作者
Gaya, DR [1 ]
Mackenzie, JF [1 ]
机构
[1] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland
关键词
D O I
10.1093/qjmed/95.9.557
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:557 / 558
页数:2
相关论文
共 50 条
  • [1] Faecal calprotectin in the assessment of Crohn's disease activity
    Gaya, DR
    Lyon, TDB
    Duncan, A
    Neilly, JB
    Han, S
    Howell, J
    Liddell, C
    Stanley, AJ
    Morris, AJ
    Mackenzie, JF
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2005, 98 (06) : 435 - 441
  • [2] Faecal calprotectin: a new marker for Crohn's disease?
    Wassell, J
    Dolwani, S
    Metzner, M
    Losty, H
    Hawthorne, A
    ANNALS OF CLINICAL BIOCHEMISTRY, 2004, 41 : 230 - 232
  • [3] Utility of faecal calprotectin to assess Crohn's disease activity in patients with an ileostomy
    Rowan, C. R.
    Alzubi, S.
    Healy, M.
    Cullen, G.
    Mulcahy, H.
    Sheridan, J.
    Doherty, G. A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S268 - S268
  • [4] UTILITY OF FAECAL CALPROTECTIN TO ASSESS CROHN'S DISEASE ACTIVITY IN PATIENTS WITH AN ILEOSTOMY
    Rowan, Catherine
    Alzubi, Shabib
    Healy, Maeve
    Cullen, Garret
    Mulcahy, Hugh E.
    Sheridan, Juliette
    Doherty, Glen A.
    GASTROENTEROLOGY, 2018, 154 (06) : S397 - S397
  • [5] Faecal calprotectin and white cell scintigraphy in the assessment of Crohn's disease activity
    Neilly, JB
    Gaya, D
    Han, S
    Howell, J
    Liddell, C
    Stanley, AJ
    MacKenzie, JF
    Duncan, A
    Lyon, D
    Gray, HW
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S216 - S216
  • [6] ELEVATED FAECAL CALPROTECTIN PREDICTS DISEASE PROGRESSION IN CROHN'S DISEASE
    Kennedy, N. A.
    Chang, J.
    Guy, M. H.
    Smith, T.
    Loh, J. T.
    Haunschmidt, D.
    Muscat, M.
    Spurio, F. Fasci
    Drummond, H. E.
    Kingstone, K.
    Noble, C. L.
    Shand, A. G.
    Satsangi, J.
    Arnott, I. D.
    Lees, C. W.
    GUT, 2013, 62 : A7 - A7
  • [7] Elevated Faecal Calprotectin Predicts Disease Progression in Crohn's Disease
    Kennedy, Nicholas A.
    Chang, Jeff
    Guy, Miriam
    Smith, Tom
    Loh, Joash T.
    Haunschmidt, David
    Muscat, Martina
    Spurio, Federica Fasci
    Drummond, Hazel E.
    Kingstone, Kathleen
    Noble, Colin
    Shand, Alan G.
    Satsangi, Jack
    Arnott, Ian D.
    Lees, Charlie W.
    GASTROENTEROLOGY, 2013, 144 (05) : S105 - S105
  • [8] Validity of stomal calprotectin measurement in assessing Crohn's disease activity
    Abeyratne, K.
    Harb, M.
    Bensted, K.
    Ghaly, S.
    Connor, S.
    Andrews, J.
    Lynch, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 125 - 125
  • [9] A faecal microbial signature, in combination with faecal calprotectin, to optimise endoscopic activity monitoring in Crohn's Disease
    Taboada-Lopez, S.
    Malagon, M.
    Amoedo, J.
    Ramio-Pujol, S.
    Busquets, D.
    Bahi, A.
    Gilabert, P.
    Rodriguez-Alonso, L.
    Manosa, M.
    Canete, F.
    Torres, P. F.
    Morales, V. J.
    Delgado-Guillena, P. G.
    Domenech, E.
    Guardiola, J.
    Serra-Pages, M.
    Garcia-Gil, L. J.
    Aldeguer, X.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2142 - I2142
  • [10] Faecal Calprotectin and Ileal Crohn's Disease: Correlation With a Small Bowel MRI Score for Disease Activity
    Fasci-Spurio, Federica
    Kennedy, Nicholas A.
    Wong, Li
    MacLean, Peter
    Satsangi, Jack
    Glancy, Stephen
    Lees, Charlie W.
    GASTROENTEROLOGY, 2014, 146 (05) : S231 - S232